Global Oncology Trial Manager – Phase III Leadership

Summit Therapeutics, Inc.; Palo Alto (CA); On-site; USD 140,000 - 210,000; Full time

Job summary

Scorpion Therapeutics in the United States (Palo Alto) is seeking a Clinical Trial Manager 2 to oversee global Phase 3 oncology studies, including NSCLC and colorectal cancer, from start-up through closeout.

The role requires leading trial operations, site selection, feasibility, activation, enrollment, monitoring, CRO oversight, and regulatory compliance, with travel up to 20%. You will partner with cross-functional teams to ensure data quality and inspection readiness.

Qualifications

• Bachelor's degree in life sciences or related field.
• 6+ years in clinical trial management within biotech/pharma.
• 5+ years managing Phase II/III oncology trials.
• Strong understanding of GCP/ICH guidelines, data assessment, and regulatory standards.

Responsibilities

• Site selection.
• Feasibility assessment.
• Trial activation and enrollment oversight.
• Monitoring and issue escalation.
• CRO oversight and management of vendor performance.
• Review of essential documents and regulatory submissions.
• Data and quality management across trials.
• Ensuring regulatory compliance and inspection readiness.
• Support trial closeout activities.
• Coordinate cross-functional teams and global study governance.

Skills

GCP/ICH knowledge

Regulatory standards

Data assessment

Trial management

Education

Bachelor's degree in life sciences

Job description

Scorpion Therapeutics in the United States (Palo Alto) is seeking a Clinical Trial Manager 2 to oversee global Phase 3 oncology studies, including NSCLC and colorectal cancer, from start-up through closeout.

The role requires leading trial operations, site selection, feasibility, activation, enrollment, monitoring, CRO oversight, and regulatory compliance, with travel up to 20%. You will partner with cross-functional teams to ensure data quality and inspection readiness.